Effects of the estrous cycle and the gender difference on hepatic drug-metabolising enzyme activities

Minoru Watanabe, Masami Tanaka, Tomonori Tateishi, Hironori Nakura, Toshio Kumai, Shinichi Kobayashi

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The aim of the present study was to investigate the effects of the estrous cycle and physiological dose of estradiol (E2) and the gender difference on several hepatic drug-metabolising enzyme activities. Eight-week old female Sprague-Dawley rats at different stages of the estrous cycle [proestrous (P), estrous (E), and diestrous (D)] and 8-week old male rats were used in this study (n = 5, respectively). Serum E2 level at D was higher than that at E and lower than that at P. The hepatic cytochrome P450 content, aniline hydroxylase, ethoxycoumarin O-deethylase and aminopyrine N-demethylase activities in male were significantly higher than those in female at any stage of the estrous cycle and these activities in female remained unchanged during the estrous cycle. Neither the estrous cycle nor the gender difference affected the cytochrome b5 content. NADPH-cytochrome c reductase (fP(Υ)) activity at P was similar to that in male, and was significantly higher than that in E and D. fP(Υ) activity was increased by the administration of physiological dose of E2 in ovariectomized rats. Uridine diphosphate glucuronyltransferase (UDP-GT) activity at E was significantly lower than that at P or D and that activity in female was significantly lower than that in male. These results indicate that the estrous cycle, especially serum E2 level, may affect both fP(Υ) and UDP-GT activities.

Original languageEnglish
Pages (from-to)477-480
Number of pages4
JournalPharmacological Research
Volume35
Issue number5
DOIs
Publication statusPublished - May 1997
Externally publishedYes

Fingerprint

Estrous Cycle
Liver
Enzymes
Pharmaceutical Preparations
Glucuronosyltransferase
Uridine Diphosphate
Aminopyrine N-Demethylase
7-Alkoxycoumarin O-Dealkylase
Aniline Hydroxylase
Cytochromes b5
NADPH-Ferrihemoprotein Reductase
Serum
Cytochrome P-450 Enzyme System
Sprague Dawley Rats
Estradiol

Keywords

  • Drug-metabolising enzymes
  • Estradiol
  • Estrous cycle
  • Sex difference

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effects of the estrous cycle and the gender difference on hepatic drug-metabolising enzyme activities. / Watanabe, Minoru; Tanaka, Masami; Tateishi, Tomonori; Nakura, Hironori; Kumai, Toshio; Kobayashi, Shinichi.

In: Pharmacological Research, Vol. 35, No. 5, 05.1997, p. 477-480.

Research output: Contribution to journalArticle

Watanabe, Minoru ; Tanaka, Masami ; Tateishi, Tomonori ; Nakura, Hironori ; Kumai, Toshio ; Kobayashi, Shinichi. / Effects of the estrous cycle and the gender difference on hepatic drug-metabolising enzyme activities. In: Pharmacological Research. 1997 ; Vol. 35, No. 5. pp. 477-480.
@article{488def0dd5e94d07ae665e5203cb0317,
title = "Effects of the estrous cycle and the gender difference on hepatic drug-metabolising enzyme activities",
abstract = "The aim of the present study was to investigate the effects of the estrous cycle and physiological dose of estradiol (E2) and the gender difference on several hepatic drug-metabolising enzyme activities. Eight-week old female Sprague-Dawley rats at different stages of the estrous cycle [proestrous (P), estrous (E), and diestrous (D)] and 8-week old male rats were used in this study (n = 5, respectively). Serum E2 level at D was higher than that at E and lower than that at P. The hepatic cytochrome P450 content, aniline hydroxylase, ethoxycoumarin O-deethylase and aminopyrine N-demethylase activities in male were significantly higher than those in female at any stage of the estrous cycle and these activities in female remained unchanged during the estrous cycle. Neither the estrous cycle nor the gender difference affected the cytochrome b5 content. NADPH-cytochrome c reductase (fP(Υ)) activity at P was similar to that in male, and was significantly higher than that in E and D. fP(Υ) activity was increased by the administration of physiological dose of E2 in ovariectomized rats. Uridine diphosphate glucuronyltransferase (UDP-GT) activity at E was significantly lower than that at P or D and that activity in female was significantly lower than that in male. These results indicate that the estrous cycle, especially serum E2 level, may affect both fP(Υ) and UDP-GT activities.",
keywords = "Drug-metabolising enzymes, Estradiol, Estrous cycle, Sex difference",
author = "Minoru Watanabe and Masami Tanaka and Tomonori Tateishi and Hironori Nakura and Toshio Kumai and Shinichi Kobayashi",
year = "1997",
month = "5",
doi = "10.1006/phrs.1997.0165",
language = "English",
volume = "35",
pages = "477--480",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press Inc.",
number = "5",

}

TY - JOUR

T1 - Effects of the estrous cycle and the gender difference on hepatic drug-metabolising enzyme activities

AU - Watanabe, Minoru

AU - Tanaka, Masami

AU - Tateishi, Tomonori

AU - Nakura, Hironori

AU - Kumai, Toshio

AU - Kobayashi, Shinichi

PY - 1997/5

Y1 - 1997/5

N2 - The aim of the present study was to investigate the effects of the estrous cycle and physiological dose of estradiol (E2) and the gender difference on several hepatic drug-metabolising enzyme activities. Eight-week old female Sprague-Dawley rats at different stages of the estrous cycle [proestrous (P), estrous (E), and diestrous (D)] and 8-week old male rats were used in this study (n = 5, respectively). Serum E2 level at D was higher than that at E and lower than that at P. The hepatic cytochrome P450 content, aniline hydroxylase, ethoxycoumarin O-deethylase and aminopyrine N-demethylase activities in male were significantly higher than those in female at any stage of the estrous cycle and these activities in female remained unchanged during the estrous cycle. Neither the estrous cycle nor the gender difference affected the cytochrome b5 content. NADPH-cytochrome c reductase (fP(Υ)) activity at P was similar to that in male, and was significantly higher than that in E and D. fP(Υ) activity was increased by the administration of physiological dose of E2 in ovariectomized rats. Uridine diphosphate glucuronyltransferase (UDP-GT) activity at E was significantly lower than that at P or D and that activity in female was significantly lower than that in male. These results indicate that the estrous cycle, especially serum E2 level, may affect both fP(Υ) and UDP-GT activities.

AB - The aim of the present study was to investigate the effects of the estrous cycle and physiological dose of estradiol (E2) and the gender difference on several hepatic drug-metabolising enzyme activities. Eight-week old female Sprague-Dawley rats at different stages of the estrous cycle [proestrous (P), estrous (E), and diestrous (D)] and 8-week old male rats were used in this study (n = 5, respectively). Serum E2 level at D was higher than that at E and lower than that at P. The hepatic cytochrome P450 content, aniline hydroxylase, ethoxycoumarin O-deethylase and aminopyrine N-demethylase activities in male were significantly higher than those in female at any stage of the estrous cycle and these activities in female remained unchanged during the estrous cycle. Neither the estrous cycle nor the gender difference affected the cytochrome b5 content. NADPH-cytochrome c reductase (fP(Υ)) activity at P was similar to that in male, and was significantly higher than that in E and D. fP(Υ) activity was increased by the administration of physiological dose of E2 in ovariectomized rats. Uridine diphosphate glucuronyltransferase (UDP-GT) activity at E was significantly lower than that at P or D and that activity in female was significantly lower than that in male. These results indicate that the estrous cycle, especially serum E2 level, may affect both fP(Υ) and UDP-GT activities.

KW - Drug-metabolising enzymes

KW - Estradiol

KW - Estrous cycle

KW - Sex difference

UR - http://www.scopus.com/inward/record.url?scp=0031149234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031149234&partnerID=8YFLogxK

U2 - 10.1006/phrs.1997.0165

DO - 10.1006/phrs.1997.0165

M3 - Article

C2 - 9299214

AN - SCOPUS:0031149234

VL - 35

SP - 477

EP - 480

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

IS - 5

ER -